Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021	2016 - 2020
Market Capitalization	87	98	93	471	544	640	Upgrade
Market Cap Growth	-26.11%	4.69%	-80.20%	-13.48%	-15.00%	479.35%	Upgrade
Enterprise Value	-44	-46	-9	311	444	565	Upgrade
Last Close Price	2.12	2.42	2.31	12.03	14.28	19.68	Upgrade
PE Ratio	-	-	16.87	-	-	-	Upgrade
PS Ratio	43.38	-	69.54	174.08	200.54	236.73	Upgrade
PB Ratio	0.62	0.67	0.57	3.11	3.26	5.49	Upgrade
P/TBV Ratio	0.61	0.67	0.57	3.10	3.27	5.53	Upgrade
EV/Sales Ratio	-	-	-	115.15	163.83	208.87	Upgrade
Debt / Equity Ratio	0.00	0.00	0.32	0.01	0.00	0.01	Upgrade
Asset Turnover	0.01	-	0.01	0.02	-	0.03	Upgrade
Quick Ratio	23.83	24.97	3.05	27.10	19.85	14.10	Upgrade
Current Ratio	23.94	25.19	3.06	27.34	20.08	14.27	Upgrade
Return on Equity (ROE)	-18.51%	-12.39%	3.24%	-23.77%	-	-30.78%	Upgrade
Return on Assets (ROA)	-5.10%	-4.25%	-5.16%	-14.95%	-	-17.54%	Upgrade
Return on Capital (ROIC)	-5.29%	-4.44%	-5.38%	-15.90%	-	-20.18%	Upgrade
Earnings Yield	-32.61%	-19.54%	5.93%	-7.77%	-6.44%	-3.48%	Upgrade
FCF Yield	-12.10%	-8.64%	-11.32%	-6.04%	-6.14%	-3.37%	Upgrade
Buyback Yield / Dilution	0.05%	-0.65%	-4.02%	-5.08%	-30.36%	-16.71%	Upgrade

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q